SEC Form 3 · accession 0000899243-18-029880
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Trojer
Officer — Chief Scientific Officer
Period of report
Nov 28, 2018
Accepted (ET)
Nov 30, 2018 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 10,277 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.08 | holding | — | — | — | — | Mar 6, 2022 | Common Stock | 2,565 | — | D |
| Stock Option (right to buy)F2 | $5.62 | holding | — | — | — | — | Nov 8, 2025 | Common Stock | 25,760 | — | D |
| Stock Option (right to buy)F3 | $7.60 | holding | — | — | — | — | Feb 18, 2026 | Common Stock | 2,270 | — | D |
| Stock Option (right to buy)F4 | $5.51 | holding | — | — | — | — | Feb 16, 2027 | Common Stock | 27,704 | — | D |
| Stock Option (right to buy)F5 | $5.51 | holding | — | — | — | — | Jul 10, 2027 | Common Stock | 4,541 | — | D |
| Stock Option (right to buy)F6 | $7.60 | holding | — | — | — | — | Mar 5, 2028 | Common Stock | 46,280 | — | D |
| Stock Option (right to buy)F7 | $8.04 | holding | — | — | — | — | Apr 22, 2028 | Common Stock | 46,280 | — | D |
| Stock Option (right to buy)F8 | $11.50 | holding | — | — | — | — | Jul 18, 2028 | Common Stock | 22,708 | — | D |
Explanation of responses
- F1This option was granted on March 7, 2012, and is fully vested.
- F2This option was granted on November 9, 2015, and is fully vested.
- F3This option was granted on February 19, 2016, and the shares underlying the options vest in equal quarterly installments through February 19, 2020.
- F4This option was granted on February 17, 2017, and the shares underlying the options vest in equal quarterly installments through February 17, 2021.
- F5This option was granted on July 11, 2017, and the shares underlying the options vest in equal quarterly installments through July 11, 2021.
- F6This option was granted on March 6, 2018, and the shares underlying the options vest in equal quarterly installments through March 6, 2022.
- F7This option was granted on April 23, 2018, and the shares underlying the options vest in equal quarterly installments through April 23, 2022.
- F8This option was granted on July 19, 2018 and is scheduled to vest in equal quarterly installments through July 19, 2022, subject to continued service.
Remarks
Exhibit Index: 24.1 Power of Attorney